CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation

Regulations
May.14
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.

Key Points

  • U.S. seizes 18 million illegal vapes;
  • Operation targets China-origin shipments;
  • Products valued at over $175 million;
  • All seized products lacked FDA authorization.
  • Release date coincided with Trump’s Beijing arrival.

2Firsts

May 13, 2026

According to U.S. Customs and Border Protection (CBP), the agency, together with the U.S. Coast Guard and the Food and Drug Administration (FDA), seized more than 18 million e-cigarette products valued at over $175 million during “Operation Red Mist.”

CBP said the operation primarily targeted maritime vape cargo shipments originating from China and focused on combating the illicit importation, transportation, and distribution of vaping products and related hazardous components.

Authorities said the enforcement effort involved intelligence analysis, cargo targeting, and interagency coordination across multiple stages of the supply chain, including pre-shipment screening, port-of-entry inspections, and post-seizure investigations.

During the operation, investigators identified shipments involving hazardous material misclassification, improper labeling, and attempts to evade taxes, duties, and regulatory oversight.

CBP said some products also violated U.S. import requirements for tobacco products, transportation safety standards for electronic devices, and environmental protection regulations.

The FDA stated that all e-cigarette products seized during Operation Red Mist lacked FDA premarket authorization and therefore could not be legally marketed in the United States.

According to FDA data, only 41 vaping products are currently authorized for legal sale in the U.S.

Diane J. Sabatino, Executive Assistant Commissioner for CBP’s Office of Field Operations, said:

“The spread of illegal e-cigarettes is alarming for communities everywhere.”

She added that frontline officers are working to prevent such products from entering the market, particularly to keep them away from young consumers.

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
Diane J. Sabatino, Executive Assistant Commissioner, Office of Field Operations, U.S. Customs and Border Protection (CBP).|Image source:CBP

CBP said the operation forms part of a broader federal crackdown on illegal vaping products aimed at preventing unsafe devices from reaching U.S. communities and retail shelves.

The agency also noted that revenue generated from counterfeit and noncompliant imports is often linked to broader criminal activities.

Public information shows CBP enforces more than 400 laws on behalf of over 40 federal agencies, with trade enforcement responsibilities covering import safety, intellectual property protection, and hazardous goods oversight.

Timing, Code Name and FDA Authorization Count

The announcement also contains several timing and wording details. CBP listed both the release date and the last-modified date as May 13, 2026. The release identified the initiative by its code name, “Operation Red Mist,” and stated: “Operation Red Mist primarily targets maritime cargo shipments originating from the People’s Republic of China and is designed to combat the illicit importation, transportation, and distribution of vapes and their hazardous components.”

CBP’s release also stated that “only 41 FDA-authorized products are permitted for U.S. marketing and distribution,” linking to FDA’s page for authorized e-cigarettes and other electronic nicotine delivery systems. FDA had announced on May 5, 2026, that it authorized four Glas ENDS products through the PMTA pathway. Including those products, the number of FDA-authorized e-cigarette products would be 45.

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP’s May 13, 2026 release states that “only 41 FDA-authorized products” are permitted for U.S. marketing and distribution. | Image source: CBP

The discrepancy suggests that CBP’s May 13 release used an authorization count that did not reflect FDA’s May 5, 2026 authorization of four Glas ENDS products. One possibility is that CBP did not update the figure when drafting or publishing the release. Another is that the text had been written and cleared for publication before FDA authorized the Glas products on May 5, and was later published on May 13 without the authorization count being updated. CBP did not disclose when the release was drafted, approved or scheduled for publication.

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
FDA’s authorized e-cigarette product page states that 45 e-cigarettes are currently authorized by the agency. | Screenshot by 2Firsts on May 14, 2026, Beijing time; source: FDA

Follow 2Firsts for the latest updates on U.S. NGPs regulation and market developments.

(Cover Image source: CBP official news page)


2FIRSTS | FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
2FIRSTS | FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
www.2firsts.com

2FIRSTS | FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
2FIRSTS | FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
www.2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09